Cargando…

Loss of TBK1 is a frequent cause of frontotemporal dementia in a Belgian cohort

OBJECTIVE: To assess the genetic contribution of TBK1, a gene implicated in amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and FTD-ALS, in Belgian FTD and ALS patient cohorts containing a significant part of genetically unresolved patients. METHODS: We sequenced TBK1 in a hospit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gijselinck, Ilse, Van Mossevelde, Sara, van der Zee, Julie, Sieben, Anne, Philtjens, Stéphanie, Heeman, Bavo, Engelborghs, Sebastiaan, Vandenbulcke, Mathieu, De Baets, Greet, Bäumer, Veerle, Cuijt, Ivy, Van den Broeck, Marleen, Peeters, Karin, Mattheijssens, Maria, Rousseau, Frederic, Vandenberghe, Rik, De Jonghe, Peter, Cras, Patrick, De Deyn, Peter P., Martin, Jean-Jacques, Cruts, Marc, Van Broeckhoven, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4691687/ https://www.ncbi.nlm.nih.gov/pubmed/26581300 http://dx.doi.org/10.1212/WNL.0000000000002220

Ejemplares similares

Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort
por: Van Mossevelde, Sara, et al.
Publicado: (2016)

The C9orf72 repeat size correlates with onset age of disease, DNA methylation and transcriptional downregulation of the promoter
por: Gijselinck, I, et al.
Publicado: (2016)

Investigating the role of filamin C in Belgian patients with frontotemporal dementia linked to GRN deficiency in FTLD-TDP brains
por: Janssens, Jonathan, et al.
Publicado: (2015)

Contribution of rare homozygous and compound heterozygous VPS13C missense mutations to dementia with Lewy bodies and Parkinson’s disease
por: Smolders, Stefanie, et al.
Publicado: (2021)

Extended FTLD pedigree segregating a Belgian GRN-null mutation: neuropathological heterogeneity in one family
por: Sieben, Anne, et al.
Publicado: (2018)

Reduced secreted clusterin as a mechanism for Alzheimer-associated CLU mutations
por: Bettens, Karolien, et al.
Publicado: (2015)

Phenotypic characteristics of Alzheimer patients carrying an ABCA7 mutation
por: Van den Bossche, Tobi, et al.
Publicado: (2016)

TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort
por: van der Zee, Julie, et al.
Publicado: (2011)

The genetics and neuropathology of frontotemporal lobar degeneration
por: Sieben, Anne, et al.
Publicado: (2012)

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability
por: Cacace, Rita, et al.
Publicado: (2019)

Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD
por: Boeynaems, Steven, et al.
Publicado: (2016)

Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration
por: Goossens, Joery, et al.
Publicado: (2018)

TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
por: van der Zee, Julie, et al.
Publicado: (2017)

Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites
por: Brouwers, N, et al.
Publicado: (2012)

No added diagnostic value of non-phosphorylated tau fraction (p-tau(rel)) in CSF as a biomarker for differential dementia diagnosis
por: Goossens, Joery, et al.
Publicado: (2017)

Patients carrying the mutation p.R406W in MAPT present with non-conforming phenotypic spectrum
por: Gossye, Helena, et al.
Publicado: (2022)

An intronic VNTR affects splicing of ABCA7 and increases risk of Alzheimer’s disease
por: De Roeck, Arne, et al.
Publicado: (2018)

Mutated CTSF in adult-onset neuronal ceroid lipofuscinosis and FTD
por: van der Zee, Julie, et al.
Publicado: (2016)

Mutated ATP10B increases Parkinson’s disease risk by compromising lysosomal glucosylceramide export
por: Martin, Shaun, et al.
Publicado: (2020)

Validation of the Erlangen Score Algorithm for Differential Dementia Diagnosis in Autopsy-Confirmed Subjects
por: Somers, Charisse, et al.
Publicado: (2019)

Promoter DNA methylation regulates progranulin expression and is altered in FTLD
por: Banzhaf-Strathmann, Julia, et al.
Publicado: (2013)

Amyloid-β(1–43) cerebrospinal fluid levels and the interpretation of APP, PSEN1 and PSEN2 mutations
por: Perrone, Federica, et al.
Publicado: (2020)

Both common variations and rare non-synonymous substitutions and small insertion/deletions in CLU are associated with increased Alzheimer risk
por: Bettens, Karolien, et al.
Publicado: (2012)

Locus-Specific Mutation Databases for Neurodegenerative Brain Diseases
por: Cruts, Marc, et al.
Publicado: (2012)

Genetics of Early-Onset Alzheimer Dementia
por: Rademakers, Rosa, et al.
Publicado: (2003)

A Pan-European Study of the C9orf72 Repeat Associated with FTLD: Geographic Prevalence, Genomic Instability, and Intermediate Repeats
por: van der Zee, Julie, et al.
Publicado: (2013)

Improved Alzheimer’s Disease versus Frontotemporal Lobar Degeneration Differential Diagnosis Combining EEG and Neurochemical Biomarkers: A Pilot Study
por: Laton, Jorne, et al.
Publicado: (2022)

Genetic Etiology of Parkinson Disease Associated with Mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 Genes: A Mutation Update
por: Nuytemans, Karen, et al.
Publicado: (2010)

NanoPack: visualizing and processing long-read sequencing data
por: De Coster, Wouter, et al.
Publicado: (2018)

Serum Daytime Melatonin Levels Reflect Cerebrospinal Fluid Melatonin Levels in Alzheimer’s Disease but Are Not Correlated with Cognitive Decline
por: Nous, Amber, et al.
Publicado: (2021)

The Use of Biomarkers and Genetic Screening to Diagnose Frontotemporal Dementia: Evidence and Clinical Implications
por: Gossye, Helena, et al.
Publicado: (2019)

The Cerebrospinal Fluid Aβ(1–42)/Aβ(1–40) Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer’s Disease in a Clinical Setting
por: Niemantsverdriet, Ellis, et al.
Publicado: (2017)

Overexpression of ALS-Associated p.M337V Human TDP-43 in Mice Worsens Disease Features Compared to Wild-type Human TDP-43 Mice
por: Janssens, Jonathan, et al.
Publicado: (2013)

Clinical review: Critical illness polyneuropathy and myopathy
por: Hermans, Greet, et al.
Publicado: (2008)

Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging
por: Ottoy, Julie, et al.
Publicado: (2019)

C-terminal TMEM106B fragments in human brain correlate with disease-associated TMEM106B haplotypes
por: T. Vicente, Cristina, et al.
Publicado: (2023)

Frontotemporal Lobar Degeneration Case with an N-Terminal TUBA4A Mutation Exhibits Reduced TUBA4A Levels in the Brain and TDP-43 Pathology
por: Van Schoor, Evelien, et al.
Publicado: (2022)

Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers()
por: Adamczuk, Katarzyna, et al.
Publicado: (2013)

Increased Aggregation Is More Frequently Associated to Human Disease-Associated Mutations Than to Neutral Polymorphisms
por: De Baets, Greet, et al.
Publicado: (2015)

Epidemic Achromobacter xylosoxidans strain among Belgian cystic fibrosis patients and review of literature
por: Cools, Piet, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eujuta6bhjo1ddeg4vn7ckk2sl